Search
for
Sort by
Research 61–90 of 684
- Chronic graft-versus-host disease – the role of dermatological treatment
- Cutaneous Adverse Drug Reactions to Antibiotics: How Much is the Extent of the Problem?
- Methotrexate injection site reactions: Case report and literature review
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- Fatal Case of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Induced by Doxycycline or Flucloxacillin in a 77-Year-Old Woman: A Rare but Serious Adverse Drug Reaction
- Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C
- Understanding fibrosing alopecia in a pattern distribution: a retrospective study with histological challenges in the diagnosis of diffuse central alopecia
- Cutaneous manifestations associated with immune checkpoint inhibitors
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Lichen planopilaris caused by wig attachment: A Case of Koebner phenomenon in Frontal Fibrosing Alopecia
- Proposal for Clinical Classification of Cutaneous Manifestations in Covid-19 and in Post Vaccination Against Sars-Cov-2: An Observational Study
- Madarosis: A marker of many Maladies
- Dermatotoxicology of microneedles (MNs) in man
- Permanent Makeup Removal Severe Complication—Case Report and Proposal of the Protocol for Its Management
- Contact Dermatitis
- DIETHYLPROPION
- TACRINE
- Nail involvement in frontal fibrosing alopecia
- Prophylaxis and Management of Skin Toxicities
- Rare and misdiagnosed entity fibrosing alopecia in a pattern distribution: A case report
- From Misdiagnosis to Targeted Therapy: A Case Report of Folliculitis Decalvans and Lichen Planopilaris Phenotypic Spectrum
- Skin toxicity induced by chemotherapy or molecular targeted therapy combined with immune checkpoint inhibitors in Asian patients: A literature review by the Japanese Pharmacist-led Oncodermatology Study Team
- Rare Cutaneous Side Effects of Imiquimod: A Review on Its Mechanisms, Diagnosis, and Management
- Diagnosis and treatment of cutaneous adverse effects of targeted therapy, antibody–drug conjugates, and immunotherapy in cancer patients: a national consensus statement by the Spanish Society of Medical Oncology and the Spanish Academy of Dermatology and Venereology
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Adverse Dermatologic Effects of Cardiovascular Drug Therapy: Part III
- Drug eruptions in dermatology
- CUTANEOUS SIDE-EFFECTS OF BETA-ADRENERGIC BLOCKERS
- Adverse cutaneous effects of psychotropic medications
- The pharmacology of methotrexate